Juxtaglomerular cells, commonly called JG cells, are specialized smooth-muscle-like cells in the kidney that produce and release renin, the enzyme that kicks off one of the body’s most powerful blood-pressure-regulating cascades. Sitting in the walls of the small arteries (afferent arterioles) that feed each kidney filtering unit, these cells act as both sensors and secretors, reading blood pressure, salt levels, and nerve signals before deciding how much renin to dump into the bloodstream. Their behavior has consequences far beyond the kidney itself, influencing everything from how much sodium you retain to how hard your heart has to pump.
Where JG Cells Sit and Why Location Matters
Each kidney contains roughly a million tiny filtration units called nephrons. Blood enters each nephron through an afferent arteriole, and JG cells cluster in the wall of that arteriole right at the entrance to the glomerulus, the ball of capillaries where blood is first filtered. This position is not accidental. It places JG cells at the exact junction where they can sense the pressure of incoming blood, receive chemical signals from the tubule downstream, and communicate with neighboring endothelial cells through direct cell-to-cell connections.
The neighborhood around JG cells is called the juxtaglomerular apparatus, which also includes a patch of specialized tubule cells known as the macula densa and a cluster of support cells called extraglomerular mesangial cells. These three cell populations work together like a local committee, exchanging chemical signals that ultimately tell JG cells whether to release more or less renin. The macula densa senses salt concentration in the tubular fluid, while the mesangial cells relay and amplify signals between the macula densa and the JG cells.
How Renin Is Made and Stored
Renin does not simply leak out of JG cells on demand. It is manufactured, processed, and packed into storage granules in a carefully staged sequence. JG cells first produce a large inactive precursor called preprorenin, which is quickly trimmed down to prorenin. Prorenin then gets packaged into small membrane-bound sacs called secretory granules, where it gradually matures into active renin. Research tracking renin and prorenin inside mouse JG cells with gold-labeled antibodies showed that prorenin appears in young and intermediate granules but not in fully mature ones, confirming that the final cleavage step, the conversion from prorenin to active renin, happens as granules mature inside the cell.1PubMed. Renin processing studied by immunogold localization of prorenin and renin in granular juxtaglomerular cells in mice treated with enalapril
Work on human JG tumor tissue further confirmed this pathway: renin is synthesized as preprorenin, rapidly converted into prorenin (a molecule of about 55,000 molecular weight), packaged into secretory granules, and processed there into active renin (about 44,000 molecular weight) before being released.2Journal of Clinical Investigation. Renin biosynthesis by human tumoral juxtaglomerular cells. Evidences for a renin precursor. When researchers cultured tumor cells in a dish, the cells still made preprorenin and prorenin but could no longer form proper granules or convert prorenin to active renin. That finding highlights how important the intact cellular architecture is for the maturation process.
JG cells actually release only a small fraction of their stored renin in response to any single stimulus. The rest stays packed in granules, ready to go. Cultured JG cells from hydronephrotic mouse kidneys showed that mature granules release their contents by fusing with the cell membrane (a process called exocytosis), while prorenin escapes through a separate, continuous “constitutive” pathway that does not require granule fusion.3PubMed. Renin processing in cultured juxtaglomerular cells of the hydronephrotic mouse kidney This dual-release system explains why both active renin and inactive prorenin are found in the bloodstream, though in different proportions.
The Three Signals That Control Renin Release
JG cells integrate at least three distinct inputs before deciding whether to secrete renin. Each input reflects a different aspect of the body’s fluid and pressure status.
Blood Pressure Sensing
JG cells are stretch-sensitive. When blood pressure in the afferent arteriole rises, the vessel wall stretches, and JG cells detect this increased transmural pressure. Higher pressure suppresses renin release; lower pressure promotes it. Experiments applying 40 mmHg of pressure to JG cell cultures showed that the renin secretion rate dropped roughly in half compared to cells at atmospheric pressure, and active renin content also decreased.4PubMed. Transmural pressure inhibits prorenin processing in juxtaglomerular cell The pressure effect depends on calcium entering the cell and on calcium being released from internal stores. Interestingly, total renin content and renin gene activity were not changed by pressure alone, meaning the cell was not making less renin, just converting and releasing less of it.
Macula Densa Signaling
The macula densa, positioned where the tubule loops back to touch its own glomerulus, monitors the concentration of sodium and chloride flowing past it. When salt delivery to this spot drops, it means either the filtration rate has fallen or the body is low on salt. Either way, the macula densa sends chemical messengers to JG cells to ramp up renin release. One of the key mediators is prostaglandin E2, which directly stimulates renin secretion. Another molecule, adenosine, plays the opposite role: it inhibits renin release and also causes the afferent arteriole to constrict. The balance between prostaglandin E2 promoting and adenosine restraining renin release helps fine-tune how much renin enters the bloodstream.5Acta Physiologica Scandinavica. Mechanisms for macula densa cell release of renin
Sympathetic Nerve Stimulation
The kidneys receive nerve fibers from the sympathetic nervous system, and these directly innervate JG cells. When the body is stressed, dehydrated, or bleeding, sympathetic nerve firing increases. Even low-level stimulation of renal sympathetic nerves can increase renin release tenfold, and this effect is almost entirely mediated through beta-1 adrenergic receptors on JG cells. Beta-blockers like metoprolol nearly abolish this nerve-driven renin surge, which is one reason beta-blockers lower blood pressure.6PubMed. The role of beta-1-adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation
The Calcium Paradox
In most secretory cells, a rise in intracellular calcium triggers the cell to release its stored products. JG cells do the opposite: higher calcium inside the cell suppresses renin secretion. This counterintuitive behavior, often called the “calcium paradox of renin release,” puzzled researchers for decades. Multiple mechanisms seem to contribute. One line of evidence suggests that calcium activates an enzyme (myosin light chain kinase) whose downstream effects block the granule release machinery.7PubMed Central. Analysis of the calcium paradox of renin secretion Another study found that calcium activates chloride channels in JG cells, lowering the intracellular chloride concentration in a way that inhibits secretion.8American Journal of Physiology. Renin release from permeabilized juxtaglomerular cells is stimulated by chloride but not by low calcium
The practical upshot is that anything opening calcium channels in JG cells tends to reduce renin release, while anything keeping calcium low or stabilizing the cell’s resting electrical state tends to promote it. This is exactly why the pressure-sensing mechanism described earlier works: stretching the cell opens calcium channels, calcium floods in, and renin release drops.
How cAMP Drives Secretion
If calcium is the brake, the intracellular messenger cAMP (cyclic adenosine monophosphate) is the accelerator. Multiple signals that stimulate renin release, including sympathetic nerve activation, prostaglandin E2 from the macula densa, and cell swelling, all converge on raising cAMP levels inside JG cells. Mice lacking key components of this pathway (beta-adrenergic receptors, the Gsα signaling protein, or certain adenylyl cyclase enzymes) have reduced renin secretion.9PubMed. Regulation of renin secretion by renal juxtaglomerular cells cAMP works partly by keeping potassium channels open, which stabilizes the cell’s electrical state far from the voltage needed to open calcium channels. In other words, cAMP helps keep the calcium brake off.
Another messenger, cGMP (cyclic guanosine monophosphate), has a split personality in JG cells. At moderate levels, cGMP can actually boost renin release by blocking an enzyme called phosphodiesterase 3 that normally breaks down cAMP. Inhibiting this enzyme lets cAMP levels rise, and renin follows.10PubMed. Control of renin secretion from rat juxtaglomerular cells by cAMP-specific phosphodiesterases But at higher concentrations or through a different route, cGMP activates its own protein kinase, which can suppress renin release by opposing cAMP-driven signaling.11PubMed. Endogenous or overexpressed cGMP-dependent protein kinases inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cells Whether cGMP ends up helping or hindering renin secretion depends on concentration and context, which gives the body another layer of fine control.
Gap Junctions and the Connexin40 Connection
JG cells do not operate in isolation. They are physically connected to neighboring endothelial cells through gap junctions, tiny protein channels that allow ions and small signaling molecules to pass directly from one cell to the next. The specific gap junction protein connexin40 turns out to be essential for two of the three major control inputs. In mice lacking connexin40, the ability of angiotensin II and blood pressure to suppress renin secretion was completely lost, while salt intake and sympathetic nerve regulation remained intact.12PubMed. Connexin40 is essential for the pressure control of renin synthesis and secretion
This finding suggests that the calcium-dependent inhibitory signals from pressure and angiotensin II need to travel through gap junctions to reach and coordinate JG cells effectively. Without those intercellular channels, JG cells become partially deaf to two of their three main regulatory inputs, and renin secretion runs inappropriately high. The result in connexin40-deficient mice is elevated renin and high blood pressure, a miniature model of what goes wrong when JG cell communication breaks down.
JG Cell Plasticity and Recruitment
One of the more striking features of JG cells is their ability to expand in number when the body needs more renin. During fetal development, renin-producing cells line large stretches of the kidney’s arterial tree. After birth, most of these cells stop making renin and become ordinary smooth muscle cells. But if the body later faces chronic demand for more renin, such as during a low-salt diet, dehydration, or treatment with certain blood-pressure medications, those former renin producers can switch back on. This phenomenon, called recruitment, means the kidney has a reserve army of cells that can re-adopt the JG cell identity when needed.13PubMed Central. Juxtaglomerular Cell Phenotypic Plasticity
Recruitment explains why people on long-term ACE inhibitors or angiotensin receptor blockers (ARBs) can develop markedly elevated renin levels. These drugs block the renin-angiotensin system downstream, which removes the normal negative feedback loop that angiotensin II exerts on JG cells.14PubMed Central. Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent With the brake lifted, existing JG cells secrete more renin, and previously dormant cells along the arteriole rejoin the effort. The result is elevated plasma renin activity, sometimes dramatically so. This is generally not harmful while someone stays on the medication, because the extra renin cannot generate angiotensin II effectively. But if the drug is suddenly stopped, all that pent-up renin can produce a rebound surge in angiotensin II and a spike in blood pressure.
When JG Cells Form Tumors
JG cell tumors, also called reninomas, are rare neoplasms that arise from JG cells themselves. They predominantly affect adolescents and young adults and produce renin autonomously, independent of the body’s normal feedback controls. The hallmark presentation is severe high blood pressure paired with low potassium, driven by the excess renin pouring into the circulation and overstimulating aldosterone production.15PubMed Central. Review of juxtaglomerular cell tumor with focus on pathobiological aspect
Under the microscope, these tumors tend to be well-encapsulated masses of uniform polygonal cells, often with a yellowish or gray-tan cut surface and areas of bleeding. The tumor cells stain positive for renin as well as for vimentin and CD34, and electron microscopy reveals distinctive diamond-shaped renin protogranules inside the cells. A series of nine surgically treated cases found that all patients had high blood pressure, elevated plasma renin, and elevated angiotensin II before surgery, and all returned to normal blood pressure and electrolyte levels after the tumor was removed.16PubMed Central. Characterization and Management of Juxtaglomerular Cell Tumor: Analysis of 9 Cases and Literature Review Most reninomas are benign, though rare reports of vascular invasion or metastasis exist. Because they are so uncommon, young patients with unexplained hypertension and low potassium may go years before the diagnosis is considered.
JG Cell Dysfunction in Diabetes and Other Diseases
Not all JG cell problems involve overproduction of renin. In diabetes, the opposite can happen. Some people with long-standing diabetes develop a condition called hyporeninemic hypoaldosteronism, in which JG cells fail to produce adequate renin. The consequences include high potassium and a mild metabolic acidosis, because without sufficient renin driving the angiotensin-aldosterone cascade, the kidneys cannot excrete potassium efficiently. Several mechanisms contribute: direct injury to JG cells from diabetic kidney damage, defective conversion of prorenin to active renin, reduced sympathetic nerve signaling to the kidney, and chronic volume expansion from salt retention, all of which suppress renin output.17International Medical Case Reports Journal. Hyporeninemic hypoaldosteronism in a patient with diabetes mellitus: an unforgettable case report
A group of inherited kidney disorders, the salt-losing tubulopathies (including Bartter syndrome), show the opposite pattern. Because these conditions cause relentless salt wasting in the tubules, the macula densa perpetually signals JG cells to produce more renin. The result is sky-high renin and aldosterone levels, yet blood pressure stays normal or even low because the kidneys keep losing salt and water. In these patients, JG cell hyperplasia (enlargement and increased cell numbers) is a compensatory response to a tubule problem, not a disease of the JG cells themselves.
JG Cells Across the Animal Kingdom
Renin-producing cells are not unique to mammals. A comparative survey across vertebrate kidneys found JG cells in tetrapods and bony fish (teleosts), though the full juxtaglomerular apparatus with a macula densa and extraglomerular mesangium appears only in mammals.18Elsevier. Juxtaglomerular apparatus in the vertebrates Lungfish have JG cells located in arterial walls far from the glomeruli, and some aglomerular fish, species whose kidneys lack filtering glomeruli entirely, still possess renin-producing cells distributed through their kidney vasculature. In birds, the tubule cells adjacent to the glomerulus have structural features that are partway between typical mammalian macula densa cells and ordinary distal tubule cells, suggesting an evolutionary progression toward the tightly integrated juxtaglomerular apparatus seen in mammals.
This broad distribution implies that renin-based blood-pressure regulation evolved long before mammals appeared, but the precise three-part feedback architecture, where JG cells, macula densa, and mesangial cells all cooperate, is a mammalian refinement. Mammals’ more demanding circulatory requirements, with consistently high blood pressures and tight sodium balance needed for warm-blooded metabolism, may have driven the evolution of this more complex sensing apparatus.
Why JG Cells Matter for Blood Pressure Drugs
A large share of modern blood-pressure medications interact with JG cells either directly or indirectly. Beta-blockers reduce renin release by blocking the sympathetic nerve input. ACE inhibitors and ARBs remove the angiotensin II feedback that restrains JG cells, causing renin levels to rise. Calcium channel blockers, depending on their type, can also influence JG cell behavior. N-type calcium channel blockers, for instance, have been studied for their effects on the angiotensin II–renin feedback loop.19American Journal of Nephrology. Effects of an N-Type Calcium Antagonist on Angiotensin II-Renin Feedback Even diuretics, by promoting salt and water loss, trigger the macula densa pathway and stimulate JG cells to make more renin.
Direct renin inhibitors like aliskiren take yet another approach: they let JG cells release renin normally but block the enzyme’s activity once it reaches the bloodstream. From the JG cell’s perspective, the reduced downstream angiotensin II still triggers feedback-driven increases in renin production, so plasma renin levels go up even though renin activity stays suppressed. Understanding how each drug class affects JG cell behavior helps explain why certain combinations of blood-pressure medications can cause exaggerated increases in renin, and why abruptly stopping some of these drugs carries rebound risks.